Selling a Veterinary Practice in the UK: Valuations, Buyers, and What to Expect

Veterinary practice sales in the UK attract some of the highest EBITDA multiples in the SME mid-market — regularly between 6x and 12x adjusted EBITDA, and occasionally beyond that for exceptional practices. The consolidation wave that began around 2013 has not abated. PE-backed groups are still acquiring, regional platforms are growing, and the buyer universe is broader than many owners assume. If you are thinking about selling, this guide covers what your practice is likely to be worth, who will buy it, and what the process actually looks like.

Contents

How is a veterinary practice valued?

Veterinary practices are valued on adjusted EBITDA — earnings before interest, tax, depreciation, and amortisation, with adjustments made for principal drawings. This is important: if you are a working principal taking a salary well below or well above market rate, a buyer will normalise that figure to reflect what it would cost to replace you clinically. If you are taking £150,000 in combined salary and dividends but a locum vet would cost £80,000 to do your clinical hours, that £70,000 difference gets added back to EBITDA before the multiple is applied.

Revenue alone is not sufficient. Buyers care about margin. A practice turning over £2m with strong systems, loyal clients, and 20% EBITDA margins is more attractive than a £3m practice running at 10% and dependent entirely on the principal vet.

What EBITDA multiples should you expect?

The range is wide, and it depends on practice type, quality, size, and which buyer is in the room.

Practice TypeTypical EBITDA Multiple RangeNotes
Companion animal (small animal only)8x – 12x+Highest demand from consolidators
Mixed practice (companion + farm/equine)6x – 9xFarm and equine revenue seen as less predictable
Equine specialist6x – 9xNiche demand; fewer buyers
Specialist referral centre9x – 13x+Strong clinical IP; highest multiples available
Emergency and out-of-hours7x – 11xGrowing demand from groups needing 24/7 coverage

These are adjusted EBITDA multiples. A companion animal practice generating £500,000 adjusted EBITDA could realistically achieve a valuation of £4m–£6m from a major consolidator. The multiple you receive depends heavily on how well you present, how competitive the sale process is, and how strategically important your practice is to a particular buyer.

What drives a premium valuation?

Not all practices at the same EBITDA level achieve the same multiple. The following factors move the dial significantly.

Practice type and revenue mix. Companion animal practices are priced highest because revenue is predictable, clients are regular, and margins are more controllable. Mixed practices with significant farm work are valued lower — large animal work is weather-dependent, relationship-dependent, and operationally complex.

Specialist referral capability. If your practice has a specialist in orthopaedics, oncology, cardiology, or internal medicine, that is a material differentiator. Referral income is high-margin and typically retained within the group post-acquisition.

RCVS Practice Standards accreditation. Practices accredited under the RCVS Practice Standards Scheme — particularly those holding Hospital or Specialist status — are valued more highly. It signals process quality, clinical governance, and staff discipline.

Site quality. A purpose-built or well-configured modern facility commands a premium over a converted house or cramped high street premises. Buyers are looking at capital expenditure requirements post-acquisition. Owned freehold is attractive; a long, well-structured lease is acceptable; a short lease with uncertain renewal is a drag on value.

Client database and loyalty. The size and quality of your active client database matters. Consolidators want to see that clients are genuinely loyal to the practice, not primarily to you personally. If the book disappears when you do, that is a risk that gets priced in.

Associate vet quality and tenure. A practice that is entirely dependent on the principal is worth less than one with a strong associate team who intend to stay. Long-serving associates with client relationships are a significant positive.

Who are the buyers?

The major PE-backed consolidators are all active acquirers. CVS Group, IVC Evidensia, Linnaeus (owned by Mars Veterinary Health), Medivet, VetPartners, and Independents (part of the Pets at Home group) are the names you will encounter most frequently. Each has a slightly different acquisition strategy — some prioritise geographic clusters, others are focused on specialist capability or out-of-hours coverage.

Beyond the nationals, there is a growing tier of regional platforms — mid-sized groups that have acquired five to fifteen practices and are building scale before their own eventual exit. These buyers can sometimes move faster and offer more flexibility on terms, though their valuation capacity may be lower than the largest groups.

Independent buyers — individual vets or small partnerships looking to buy their first or second practice — exist but are financially constrained compared to corporate buyers. They are relevant for smaller practices or where a sale to a corporate is not wanted.

Running a structured process with multiple buyers in the room simultaneously is the most reliable route to achieving a competitive multiple.

What is the CMA's role in veterinary acquisitions?

The Competition and Markets Authority launched a market investigation into the veterinary sector in 2024, examining concerns about consolidation, pricing, and consumer choice. This is worth understanding, but it should not deter you from selling.

For most individual practice sales, the CMA investigation does not directly affect your transaction. The CMA's scrutiny is focused on systemic market behaviour and larger group acquisitions, not on the purchase of a single practice by a consolidator. That said, consolidators are navigating the regulatory environment carefully, and it is reasonable to ask any buyer how the CMA investigation affects their acquisition appetite and timeline.

For practice owners with particularly dominant local market positions — for example, a practice that is the only provider across a wide rural area — it is worth taking legal advice on whether a specific transaction could attract scrutiny.

What happens to your staff?

This is frequently the most sensitive part of a veterinary practice sale, and it deserves honest attention.

Corporate buyers need the clinical team to stay. A practice without its vets is an empty building and a client list. Most consolidators will offer retention bonuses to key associates and support staff, with payment structured over 12 to 24 months post-completion. Employment terms will transfer under TUPE (Transfer of Undertakings (Protection of Employment) Regulations), meaning staff cannot be dismissed simply because of a change of ownership.

RCVS registration requires a named Veterinary Surgeon to be responsible for the professional direction of the practice. As a selling principal, you will need to agree with the buyer how and when this responsibility transfers. Some deals include a 12–24 month earn-out period during which you remain in post; others bring in a clinical director from within the group immediately. This needs to be negotiated explicitly in the Heads of Terms.

Staff communication is a common source of anxiety for selling principals. Most buyers prefer to keep the sale confidential until exchange of contracts, at which point a structured communication plan is agreed. Getting this wrong — staff finding out prematurely through rumour — can destabilise the team at exactly the wrong moment.

What does the sale process look like?

A structured sale of a UK veterinary practice typically takes six to twelve months from preparation to completion.

  1. Preparation. Clean up your management accounts, normalise EBITDA, review your RCVS accreditations, and ensure your Companies House filings are current. Address any obvious risks a buyer will find in due diligence.
  2. Information memorandum. A detailed document covering your financial performance, clinical capability, staff structure, site details, and client base. This is what buyers assess before making indicative offers.
  3. Buyer outreach. Approach a shortlist of appropriate buyers — typically a mix of the major consolidators and relevant regional platforms — under NDA.
  4. Indicative offers. Buyers submit non-binding valuations. This is where you compare not just headline multiples but deal structure, earn-out terms, and retention requirements.
  5. Preferred buyer and Heads of Terms. You select a preferred buyer and agree Heads of Terms (HoTs). These are non-binding but set the framework for the legal process.
  6. Due diligence. The buyer's lawyers and accountants examine your financials, contracts, RCVS records, lease, employment terms, and clinical governance. Expect this to take eight to twelve weeks.
  7. Share Purchase Agreement (SPA). The legal agreement is negotiated and agreed. Warranties, indemnities, and any earn-out mechanics are finalised here.
  8. Completion. Funds transfer. RCVS notifications are made. Staff are informed according to the agreed communication plan.

If you are comparing valuations across sectors or want to understand how veterinary multiples sit within the broader UK M&A market, the EBITDA Multiples by Sector UK 2026 guide provides a useful benchmark. If you are also considering a practice sale in an adjacent healthcare sector, the Selling a Dental Practice in the UK guide covers a comparable consolidation-driven market with many structural similarities.

FAQ

What is a veterinary practice typically worth in the UK? Most companion animal practices are valued at between 8x and 12x adjusted EBITDA. For a practice generating £400,000 adjusted EBITDA, that implies a valuation range of roughly £3.2m to £4.8m. Mixed or farm-heavy practices attract lower multiples, typically 6x to 9x. Specialist referral centres can exceed 12x.

Do I need to stay on after the sale? This depends on the deal structure. Many consolidators will ask the principal to remain for a transitional period of 12 to 24 months, particularly if an earn-out is included. The RCVS also requires a named Veterinary Surgeon to be responsible for the practice, so the handover of that responsibility needs to be planned carefully.

Will the CMA investigation affect my sale? For most individual practice sales, no. The CMA's 2024 market investigation is focused on systemic consolidation and group-level behaviour. A single-practice sale to a corporate buyer is unlikely to trigger CMA scrutiny unless the practice has unusual local market dominance.

What tax will I pay when I sell? If you sell the shares in your practice company, the gain is subject to Capital Gains Tax. Business Asset Disposal Relief (BADR) may reduce the effective rate to 14% on qualifying gains up to £1m (from April 2026). Gains above the BADR threshold are taxed at 24%. If you sell assets rather than shares, the tax treatment differs. This article contains general information only and does not constitute financial or tax advice. Every business sale is different. Speak to a qualified UK tax adviser about your specific situation before making any decisions.

How long does a veterinary practice sale take? Typically six to twelve months from preparation to completion. Due diligence alone takes eight to twelve weeks once a buyer is in place. Complex deals involving multiple sites or earn-out negotiations can run longer.

What can I do to increase the value of my practice before selling? The most effective steps are: reducing personal dependency by building a strong associate team, achieving or maintaining RCVS Practice Standards accreditation, improving your management accounts so EBITDA is clearly evidenced, ensuring your lease has sufficient term remaining, and investing in the physical premises if they are below the standard a buyer would expect. These steps are most effective when started two to three years before a planned sale.

Ready to get a sense of what your practice might be worth? Use the free valuation calculator on the Succession Group website to generate an indicative valuation range based on your sector, revenue, and EBITDA. It takes under five minutes and gives you a useful starting point before engaging with any buyer.